Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MOUNTAINEER: A Phase II, Open Label Study of Tucatinib Combined With Trastuzumab in Patients With HER2+ Metastatic Colorectal Cancer

NCT03043313 is registered in ClinicalTrials.gov with Seagen Inc. as lead sponsor.

NCT NCT03043313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03043313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MOUNTAINEER: A Phase II, Open Label Study of Tucatinib Combined With Trastuzumab in Patients With HER2+ Metastatic Colorectal Cancer
Lead sponsor
Seagen Inc.
Phase
Phase 2
Overall status
Completed
Start date
June 23, 2017
Completion date
November 2, 2023
Enrollment
117 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal adenocarcinoma